LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
- Graves Disease Sarah Zielsdorf, MD, MS
- Hashimotos Kent Holtorf, MD
- LDN and Cellular Hypothyroidism: When TSH is normal but Reverse T3 is Elevated Carrie Jones, ND
- LDN and Bioidentical Hormones Harpal Bains, MD
- The Gut-Thyroid Connection, Profounded but Under Appreciated Michael Ruscio, MD
- Patient selection and inflammation Dana Keaton, ND
- LDN and Multiple Sclerosis Pamela W. Smith, MD, MPH, MS
- Compounding LDN Mark Mandel, Pharm D